BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 11112772)

  • 1. DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation.
    Ping YH; Rana TM
    J Biol Chem; 2001 Apr; 276(16):12951-8. PubMed ID: 11112772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro.
    Wada T; Takagi T; Yamaguchi Y; Watanabe D; Handa H
    EMBO J; 1998 Dec; 17(24):7395-403. PubMed ID: 9857195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Tat: coping with negative elongation factors.
    Garber ME; Jones KA
    Curr Opin Immunol; 1999 Aug; 11(4):460-5. PubMed ID: 10448148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences.
    Bourgeois CF; Kim YK; Churcher MJ; West MJ; Karn J
    Mol Cell Biol; 2002 Feb; 22(4):1079-93. PubMed ID: 11809800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.
    Zhou M; Halanski MA; Radonovich MF; Kashanchi F; Peng J; Price DH; Brady JN
    Mol Cell Biol; 2000 Jul; 20(14):5077-86. PubMed ID: 10866664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat.
    Brès V; Gomes N; Pickle L; Jones KA
    Genes Dev; 2005 May; 19(10):1211-26. PubMed ID: 15905409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between DSIF (DRB sensitivity inducing factor), NELF (negative elongation factor), and the Drosophila RNA polymerase II transcription elongation complex.
    Missra A; Gilmour DS
    Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11301-6. PubMed ID: 20534440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation.
    Isel C; Karn J
    J Mol Biol; 1999 Jul; 290(5):929-41. PubMed ID: 10438593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
    Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
    Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH.
    Wada T; Orphanides G; Hasegawa J; Kim DK; Shima D; Yamaguchi Y; Fukuda A; Hisatake K; Oh S; Reinberg D; Handa H
    Mol Cell; 2000 Jun; 5(6):1067-72. PubMed ID: 10912001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
    Zhou Q; Chen D; Pierstorff E; Luo K
    EMBO J; 1998 Jul; 17(13):3681-91. PubMed ID: 9649438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tat-associated kinase (P-TEFb): a component of transcription preinitiation and elongation complexes.
    Ping YH; Rana TM
    J Biol Chem; 1999 Mar; 274(11):7399-404. PubMed ID: 10066804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.
    Garber ME; Mayall TP; Suess EM; Meisenhelder J; Thompson NE; Jones KA
    Mol Cell Biol; 2000 Sep; 20(18):6958-69. PubMed ID: 10958691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcription elongation factors NELF, DSIF and P-TEFb control constitutive transcription in a gene-specific manner.
    Fujita T; Piuz I; Schlegel W
    FEBS Lett; 2009 Sep; 583(17):2893-8. PubMed ID: 19654008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.
    Zhu Y; Pe'ery T; Peng J; Ramanathan Y; Marshall N; Marshall T; Amendt B; Mathews MB; Price DH
    Genes Dev; 1997 Oct; 11(20):2622-32. PubMed ID: 9334325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription.
    Zhou M; Nekhai S; Bharucha DC; Kumar A; Ge H; Price DH; Egly JM; Brady JN
    J Biol Chem; 2001 Nov; 276(48):44633-40. PubMed ID: 11572868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.
    Zhou M; Deng L; Lacoste V; Park HU; Pumfery A; Kashanchi F; Brady JN; Kumar A
    J Virol; 2004 Dec; 78(24):13522-33. PubMed ID: 15564463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-specific recruitment of positive and negative elongation factors during stimulated transcription of the MKP-1 gene in neuroendocrine cells.
    Fujita T; Ryser S; Tortola S; Piuz I; Schlegel W
    Nucleic Acids Res; 2007; 35(3):1007-17. PubMed ID: 17259211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of activated transcription complex Pol II-DSIF-PAF-SPT6.
    Vos SM; Farnung L; Boehning M; Wigge C; Linden A; Urlaub H; Cramer P
    Nature; 2018 Aug; 560(7720):607-612. PubMed ID: 30135578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domains in the SPT5 protein that modulate its transcriptional regulatory properties.
    Ivanov D; Kwak YT; Guo J; Gaynor RB
    Mol Cell Biol; 2000 May; 20(9):2970-83. PubMed ID: 10757782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.